首页> 外文OA文献 >Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

【2h】

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

机译：个性化药物开发和报销方面的挑战—支付者和制造商的观点以及对健康经济学和结果研究的启示：ISPOR个性化医学特别兴趣小组的报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Faulkner Eric; Annemans Lieven; Garrison Lou; Helfand Mark; Holtorf Anke-Peggy; Hornberger John; Hughes Dyfrig; Li Tracy; Malone Daniel; Payne Katherine; Siebert Uwe; Towse Adrian; Veenstra David; Watkins John;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: A report of the ISPOR personalized medicine special interest group [J] . FaulknerE., AnnemansL., GarrisonL., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2012,第8期

机译：个性化药品付款人和制造商的观点在发展和报销方面的挑战以及对健康经济学和结果研究的影响：ISPOR个性化医学特别兴趣小组的报告
2. Sun , S . Socio‐Economics of Personalized Medicine in Asia . London and New York : Routledge . 2017 . 198 pp. ￡110 (hbk) ISBN 978‐1138933835 Sun , S Sun Sun , S S . Socio‐Economics of Personalized Medicine in Asia Socio‐Economics of Personalized Medicine in Asia . London and New York London and New York : Routledge Routledge . 2017 2017 . 198 198 pp. ￡110 (hbk) ISBN 978‐1138933835 [J] . Davey Gareth Sociology of health & illness . 2018,第5期

机译：太阳，s。亚洲个性化医学的社会经济。伦敦和纽约：Routledge。 2017年。 198年PP。£110（HBK）ISBN 978-1138933835 Sun，S Sun Sun，S S。亚洲个性化医学中个性化医学的社会经济学。伦敦和纽约伦敦和纽约：Routledge Routledge。 2017年2017年。 198 198年PP。£110（HBK）ISBN 978-1138933835
3. Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay [J] . Julia R. Trosman, Stephanie L. Van Bebber, Kathryn A. Phillips Journal of Oncology Practice . 2010,第5期

机译：个性化医疗保险政策的制定：私人付款人对制定21基因检测政策的看法
4. Healthcare Transformation Towards Personalized Medicine - Chances and Challenges [C] . Bernd BLOBEL, Pekka RUOTSALAINEN International Conference on Wearable Micro and Nano Technologies for Personalized Health . 2019

机译：医疗保健转型对个性化医学 - 机会和挑战
5. Race, Genes and Health: Public Conceptions about the Effectiveness of Race-Based Medicine and Personalized Genomic Medicine. [D] . Feldman, Naumi Mira. 2014

机译：种族，基因与健康：关于基于种族的医学和个性化基因组医学有效性的公众观念。
6. Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay [O] . Julia R. Trosman, Stephanie L. Van Bebber, Kathryn A. Phillips 2010

机译：个性化医疗保险政策的制定：私人付款人对制定21基因检测政策的看法
7. Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group [O] . Faulkner, E., Annemans, L., Garrison, L., 2012

机译：个人医学的发展和报销面临的挑战 - 支付者和制造商的观点以及对卫生经济学和成果研究的启示：IspOR个性化医学特别兴趣小组的报告

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

著录项

引文网络

相似文献

相关主题

期刊订阅